Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
33,763,352
-
Share change
-
+1,224,299
-
Total reported value
-
$1,277,904,525
-
Put/Call ratio
-
46%
-
Price per share
-
$37.85
-
Number of holders
-
150
-
Value change
-
+$46,542,763
-
Number of buys
-
72
-
Number of sells
-
77
Institutional Holders of AERIE PHARMACEUTICALS INC - COM (AERI) as of Q4 2016
As of 31 Dec 2016,
AERIE PHARMACEUTICALS INC - COM (AERI) was held by
150 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
33,763,352 shares.
The largest 10 holders included
JENNISON ASSOCIATES LLC, WELLINGTON MANAGEMENT GROUP LLP, ADAGE CAPITAL PARTNERS GP, L.L.C., DEERFIELD MANAGEMENT CO, BlackRock Fund Advisors, Foresite Capital Management III, LLC, Foresite Capital Management II, LLC, ORBIMED ADVISORS LLC, Partner Fund Management, L.P., and VANGUARD GROUP INC.
This page lists
150
institutional shareholders reporting positions in this security
for the Q4 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.